A lofty new transportation option could be touching down on the Treasure Coast. Approvals still needed before service could ...

A personal look at a vintage Piper Archer and what makes it special in the skies. Fetterman Slams Trump: ‘Do Not Threaten Members of Congress — Ever’ Taps may run dry in this country, where the water ...

The article features a 2023 Piper Archer LX as "Today's Top Pick," offering a pristine, near-new aircraft (120 hours) without factory lead times and with initial depreciation already absorbed. This LX ...

Archer is developing electric vertical takeoff and landing aircraft, also known as flying taxis. Some experts project the urban air mobility market could reach $1 trillion by 2040. It aims to launch ...

Archer Aviation (NYSE:ACHR) saw its stock plunge last week following its third-quarter earnings report and the unexpected announcement of acquiring Hawthorne Municipal Airport in Los Angeles for $126 ...

Archer Aviation Inc (NYSE:ACHR) reported third-quarter financial results after the market close on Thursday. Here’s what investors need to know. Q3 Highlights: Archer Aviation reported a third-quarter ...

William J. “Jim” Archer, III, 74, awesome father to Chelsea and Wills, beloved husband to Toni, made a peaceful transition to heaven on October 15, 2025, after a years-long struggle with COPD. At the ...

This story has been updated with new role in upcoming major sporting events. Electric vertical takeoff and landing aircraft company Archer Aviation Inc. was named by Los Angeles Sports & Entertainment ...

Archer Aviation stock is losing steam after flying high yesterday. Investors were disappointed that speculation about Tesla entering the eVTOL industry didn't pan out. Archer is a popular stock, but ...

After an announcement last week, eVTOL developer Archer Aviation completed display flights to the public at the 2025 California International Air Show. This public display was Archer’s latest aerial ...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the activation of the NRG Oncology trial, ARCHER (NRG-GU015), a ...